Differential effect of PYY1-36 and PYY3-36 on gastric emptying in man

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Differential effect of PYY1-36 and PYY3-36 on gastric emptying in man. / Witte, A-B; Grybäck, P; Holst, Jens Juul; Hilsted, L; Hellström, P M; Jacobsson, H; Schmidt, P T.

I: Regulatory Peptides, Bind 158, Nr. 1-3, 2009, s. 57-62.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Witte, A-B, Grybäck, P, Holst, JJ, Hilsted, L, Hellström, PM, Jacobsson, H & Schmidt, PT 2009, 'Differential effect of PYY1-36 and PYY3-36 on gastric emptying in man', Regulatory Peptides, bind 158, nr. 1-3, s. 57-62. https://doi.org/10.1016/j.regpep.2009.07.013

APA

Witte, A-B., Grybäck, P., Holst, J. J., Hilsted, L., Hellström, P. M., Jacobsson, H., & Schmidt, P. T. (2009). Differential effect of PYY1-36 and PYY3-36 on gastric emptying in man. Regulatory Peptides, 158(1-3), 57-62. https://doi.org/10.1016/j.regpep.2009.07.013

Vancouver

Witte A-B, Grybäck P, Holst JJ, Hilsted L, Hellström PM, Jacobsson H o.a. Differential effect of PYY1-36 and PYY3-36 on gastric emptying in man. Regulatory Peptides. 2009;158(1-3):57-62. https://doi.org/10.1016/j.regpep.2009.07.013

Author

Witte, A-B ; Grybäck, P ; Holst, Jens Juul ; Hilsted, L ; Hellström, P M ; Jacobsson, H ; Schmidt, P T. / Differential effect of PYY1-36 and PYY3-36 on gastric emptying in man. I: Regulatory Peptides. 2009 ; Bind 158, Nr. 1-3. s. 57-62.

Bibtex

@article{44dfbd20335311df8ed1000ea68e967b,
title = "Differential effect of PYY1-36 and PYY3-36 on gastric emptying in man",
abstract = "Peptide tyrosine-tyrosine (PYY) is a prandially controlled hormone in endocrine ileal and colonic mucosa cells. In plasma, PYY appears as full-length PYY1-36 and truncated PYY3-36. Both have different pharmacological profile, and PYY3-36 seems to inhibit food intake. We aimed at investigating the effect of intravenously administered PYY1-36 and PYY3-36 on gastric emptying and short-term metabolic control. Eight healthy adults were studied in single-blinded, randomized design. At separate occasions, intravenous infusion of saline, PYY1-36 or PYY3-36 (0.8 pmol kg(-1) min(-1)) and a radio-labelled omelette were given. Gastric emptying (scintigraphy), appetite ratings (VAS), and plasma concentrations of insulin, glucose, GLP-1 and PYY were measured. PYY3-36 and PYY1-36 both inhibited gastric emptying, PYY3-36 most effectively. Half-emptying time was prolonged from 63.1+/-5.2 (saline) to 87.0+/-11.5 min (PYY3-36), whereas retention at 120 min was 2.5+/-1.4% for saline, 10.7+/-4.4 for PYY1-36 and 15.8+/-4.4 for PYY3-36. Neither form influenced glucose or GLP-1 concentrations, but both decreased the postprandial rise in insulin. PYY3-36 induced nausea (VAS increase 47.5+/-22.6 mm) and decreased prospective consumption (VAS change 39.5+/-7.7 mm). In conclusion, PYY3-36's reducing effect upon food intake might be mediated by a decreased gastric emptying rate.",
author = "A-B Witte and P Gryb{\"a}ck and Holst, {Jens Juul} and L Hilsted and Hellstr{\"o}m, {P M} and H Jacobsson and Schmidt, {P T}",
note = "Keywords: Adult; Appetite; Blood Glucose; Female; Gastric Emptying; Glucagon-Like Peptide 1; Humans; Insulin; Male; Nausea; Peptide YY; Single-Blind Method",
year = "2009",
doi = "10.1016/j.regpep.2009.07.013",
language = "English",
volume = "158",
pages = "57--62",
journal = "Regulatory Peptides",
issn = "0167-0115",
publisher = "Elsevier",
number = "1-3",

}

RIS

TY - JOUR

T1 - Differential effect of PYY1-36 and PYY3-36 on gastric emptying in man

AU - Witte, A-B

AU - Grybäck, P

AU - Holst, Jens Juul

AU - Hilsted, L

AU - Hellström, P M

AU - Jacobsson, H

AU - Schmidt, P T

N1 - Keywords: Adult; Appetite; Blood Glucose; Female; Gastric Emptying; Glucagon-Like Peptide 1; Humans; Insulin; Male; Nausea; Peptide YY; Single-Blind Method

PY - 2009

Y1 - 2009

N2 - Peptide tyrosine-tyrosine (PYY) is a prandially controlled hormone in endocrine ileal and colonic mucosa cells. In plasma, PYY appears as full-length PYY1-36 and truncated PYY3-36. Both have different pharmacological profile, and PYY3-36 seems to inhibit food intake. We aimed at investigating the effect of intravenously administered PYY1-36 and PYY3-36 on gastric emptying and short-term metabolic control. Eight healthy adults were studied in single-blinded, randomized design. At separate occasions, intravenous infusion of saline, PYY1-36 or PYY3-36 (0.8 pmol kg(-1) min(-1)) and a radio-labelled omelette were given. Gastric emptying (scintigraphy), appetite ratings (VAS), and plasma concentrations of insulin, glucose, GLP-1 and PYY were measured. PYY3-36 and PYY1-36 both inhibited gastric emptying, PYY3-36 most effectively. Half-emptying time was prolonged from 63.1+/-5.2 (saline) to 87.0+/-11.5 min (PYY3-36), whereas retention at 120 min was 2.5+/-1.4% for saline, 10.7+/-4.4 for PYY1-36 and 15.8+/-4.4 for PYY3-36. Neither form influenced glucose or GLP-1 concentrations, but both decreased the postprandial rise in insulin. PYY3-36 induced nausea (VAS increase 47.5+/-22.6 mm) and decreased prospective consumption (VAS change 39.5+/-7.7 mm). In conclusion, PYY3-36's reducing effect upon food intake might be mediated by a decreased gastric emptying rate.

AB - Peptide tyrosine-tyrosine (PYY) is a prandially controlled hormone in endocrine ileal and colonic mucosa cells. In plasma, PYY appears as full-length PYY1-36 and truncated PYY3-36. Both have different pharmacological profile, and PYY3-36 seems to inhibit food intake. We aimed at investigating the effect of intravenously administered PYY1-36 and PYY3-36 on gastric emptying and short-term metabolic control. Eight healthy adults were studied in single-blinded, randomized design. At separate occasions, intravenous infusion of saline, PYY1-36 or PYY3-36 (0.8 pmol kg(-1) min(-1)) and a radio-labelled omelette were given. Gastric emptying (scintigraphy), appetite ratings (VAS), and plasma concentrations of insulin, glucose, GLP-1 and PYY were measured. PYY3-36 and PYY1-36 both inhibited gastric emptying, PYY3-36 most effectively. Half-emptying time was prolonged from 63.1+/-5.2 (saline) to 87.0+/-11.5 min (PYY3-36), whereas retention at 120 min was 2.5+/-1.4% for saline, 10.7+/-4.4 for PYY1-36 and 15.8+/-4.4 for PYY3-36. Neither form influenced glucose or GLP-1 concentrations, but both decreased the postprandial rise in insulin. PYY3-36 induced nausea (VAS increase 47.5+/-22.6 mm) and decreased prospective consumption (VAS change 39.5+/-7.7 mm). In conclusion, PYY3-36's reducing effect upon food intake might be mediated by a decreased gastric emptying rate.

U2 - 10.1016/j.regpep.2009.07.013

DO - 10.1016/j.regpep.2009.07.013

M3 - Journal article

C2 - 19651163

VL - 158

SP - 57

EP - 62

JO - Regulatory Peptides

JF - Regulatory Peptides

SN - 0167-0115

IS - 1-3

ER -

ID: 18700457